Ophthalmic Therapeutic Drugs: Technologies and Global Markets

The overall ophthalmic sector grew to $15.5 billion in 2009 (as compared to $14.4 billion in 2008) and is expected to grow to $20.6 billion in 2014, showing a compound annual growth rate (CAGR) of 5.9%.

Learn about the market for ophthalmic drugs and get forecasts by product, product category, and by company from 2009 through 2014...

Use this report to:

• Receive current and projected product forecasts during the forecast period (2009 to 2014) as well as new products approved in 2009 by the FDA and those products expected to be approved within the forecast period
• Understand emerging markets by disease segment as an aging demographic that will change the market dynamic, emerging players and technologies, strategies for accessing emerging markets and specific disease segments and geographies in order to allocate resources and make effective decisions
• See 5 year projections and trends that quantify, forecast and analyze the market for ophthalmic drugs, and to provide a range of market information from detailed product analysis within disease subsegments to overall industry trends
• Determine the most important market drivers: the introduction of combination therapies, which are expected to continue to contribute substantially to market growth through the forecast period.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.